BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nalbuphine

A narcotic used as a pain medication. It appears to be an agonist at KAPPA RECEPTORS and an antagonist or partial agonist at MU RECEPTORS.

298+ PubMed studies analyzed · 80 RCTs · Evidence Score: 56.3

Research Domains

Nalbuphine has been studied across 14 research domains including 💊 Pain, 😴 Sleep, 🫁 Respiratory, 🌤️ Mood & Depression, 🫁 Liver & Detox. The primary research focus is 💊 Pain with 68% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nalbuphine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Butorphanol
7 shared targets
Naloxone
8 shared targets
Oxycodone
5 shared targets
Meperidine
5 shared targets
Etorphine
4 shared targets
Dihydromorphine
4 shared targets
Morphine
6 shared targets
hydrocodone
4 shared targets
Levallorphan
5 shared targets
Levorphanol
6 shared targets
Loading evidence profile...

This evidence profile for Nalbuphine is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.